Zurueck zur Suche

Reporte zur Charge U003450

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 2 NY 2 VA 1 IN 1 IA 1

VAERS 1849148

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003450

schwer
Staat
VA
Alter
1,0
Geschlecht
F
Eingang
06.11.2021
Impfdatum
04.11.2021
Beginn
06.11.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Febrile convulsion Irritability Lethargy Pyrexia

Symptomtext

Symptoms were fussy, lethargic and low grade fever for 24 hours, then lethargy for 2nd 24 hours and mid level fever, then febrile seizure at hour 50 post vaccines

Weitere VAERSDATA-Felder
Praegender Schweregrund
Febrile convulsion
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2223929

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003450

mild
Staat
TX
Alter
1,9
Geschlecht
F
Eingang
08.04.2022
Impfdatum
11.03.2022
Beginn
11.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Injection site swelling Ocular hyperaemia Periorbital swelling Rash Rash erythematous Rash papular Skin discolouration Skin swelling Urticaria Wheezing

Symptomtext

She began with a rash with red whelps, with eyes red and puffy, starting with one and then the other. Her hands became erythematous and puffy. She did not have cough wheezing, hoarseness, or difficulty breathing. She was advised to give a 5 ml dose of benadryl every 4-6 hours and to go to the ER if her symptoms worsened. Called back the next day to follow up. Mom had given benadryl schedule for 24 hours, and she had improved. The first 24 hours, the rash was constant and she had to keep her on hte benadryl. On a visit with her on 3/14 (2 days later), mom reported she was continuing to develop whelps, white and red raised areas that started at her feet , moved up and then went down, multiple cycles. On 3/14 this happened 4 times. She had stopped the benadryl after the first day. Mom noted the shot sites were still swollen as well. The rash had also flared after eating some ice cream that she had never reacted to before. Mom had had to use albuterol just that day for some wheezing. She was started back on benadryl and famotidine was added as well as a prednisolone taper.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
No tests performed
Aktuelle Erkrankungen
No recent illness or allergy
Vorgeschichte
history of recurrent wheezing and recurrent congestion episodes with subsequent ear infections.
Andere Medikamente
none
Allergien
Rash on Augmentin a year ago
Vorherige Impfungen
-

VAERS 2355867

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003450

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
03.07.2022
Impfdatum
20.06.2022
Beginn
20.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE provided; Nurse calling states she inadvertently administered expired VAQTA to a patient.; This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The medical history, concurrent conditions, drug reactions or allergies and concomitants therapies were not mentioned. On 20-JUN-2022, the patient was vaccinated inadvertently with an expired dose of Hepatitis A Vaccine, inactivated (VAQTA) (Expired vaccine used), formulation: intramuscular injection, dose: 0.5 milliliter, batch # U003450 expiration date: 02-MAY-2022, (strength, vaccination schedule, and anatomical site of administration were not reported). It was stated that the vaccine had been stored at the appropriate storage condition, specified in the product label, through the date of administration. No additional adverse event details provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2302883

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003450

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
31.05.2022
Impfdatum
06.05.2022
Beginn
06.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; administration of an expired VAQTA; This spontaneous report was received from a pharmacist and referred to a patient of unknown age and gender. The patient's medical history, concurrent condition, and concomitant medication were not provided. On 06-MAY-2022, the patient was vaccinated with 1 dose of expired Hepatitis A Vaccine, Inactivated (VAQTA) (strength, and route were not reported; valid lot# U003450 with expiration date: 02-MAY-2022) for prophylaxis (expired product administered). The vaccine was stored within the recommended storage range until the administration. No additional adverse event reported (no adverse event). This case is non-valid due to the lack of patient's identifiers.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2277397

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003450

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
14.05.2022
Impfdatum
12.05.2022
Beginn
12.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Medical assistant calling to report a dose of VAQTA that was administered after its expiration date. Date expired: 5/2/2022, date administered: 5/12/2022. Caller verified that the vaccine had no undergone any temperature excursions. No PQC. No addtio; This spontaneous report was received from a medical assistant, referring to patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported. On 12-MAY-2022, the patient was vaccinated with and expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) lot# U003450, expiration date 02-MAY-2022, for prophylaxis (strength, dose, route and frequency were not reported) (Expired product administered). The vaccine had not undergone any temperature excursions. No PQC. No additional information.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2259587

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003450

gering
Staat
IA
Alter
40,0
Geschlecht
F
Eingang
30.04.2022
Impfdatum
01.03.2022
Beginn
01.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product use issue Underdose

Symptomtext

No additional AEs were reported; patient received less than the recommended dose of VAQTA. An adult received a pediatric dose of VAQTA on 3/1/2022. No additional AEs were reported, no further information provided.; An adult received a pediatric dose of VAQTA on 3/1/2022.; This spontaneous report, received from an HCP, refers to a 40-year-old female patient. The patient's concurrent conditions included neck pain, migraine, fibromyalgia, and general symptoms. Concomitant therapies and medical history were not reported. On 01-MAR-2022, a medication error occurred in the dispensing process; the patient was vaccinated, by a trained healthcare professional, with a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) 0.5 milliliters/one time, lot #U003450, expiration date: 02-MAY-2022, administered intramuscularly in the left arm for prophylaxis, with hepatitis b vaccine (HEPATITIS-B), lot #4345R, expiration date: 11-AUG-2023, administered intramuscularly (strenght, formulation, and indication were not provided); and coronavirus disease vaccine 2019 (COVID-19), lot #FK9894, expiration date: 30-Apr-2022 (strenght, formulation, route of administration, and indication were not provided). It was stated that the vaccine was not used in accordance with the instruction leaflet. The vaccine was not available for return or evaluation as it had been administered. The vaccination error was reported to the physician and manufacturer. No other adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Fibromyalgia; General symptom; Migraine; Neck pain
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1954043

MERCK & CO. INC. · HEP A (VAQTA) · Charge U003450

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
16.12.2021
Impfdatum
-
Beginn
17.11.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Syringe issue

Symptomtext

No adverse event; Broken VAQTA PFS/ Broken Syringe Barrel/ Cracked or Broken Luer Lock (Needle Attachment Issues), Broken Finger Flange; Caller reports one broken Hepatitis A vaccine, inactivated(VAQTA) pre-filled syringe (PFS). No adverse event (AE) or additional PQCs reported. Caller would send pictures and hold product for return. QUESTION SECTION: Medium Risk: Broken Syringe Barrel, High Risk: Cracked or Broken Luer Lock (Needle Attachment Issues), Broken Finger Flange. Notes for DPOC: Please provide a detailed description of the defect using the questions below: Is there a crack? NO o If yes, describe the size, shape & depth of the crack: NA o Provide the exact location of the crack on the syringe: NA; Is the syringe broken into 2 or more pieces? YES, If yes, describe in detail how it is broken: (e.g shattered, broken in half etc.) Tip is broken off o Provide the exact location of the breakage on the syringe? Tip - leur-lock is broken off o Does the syringe have a broken component? YES (e.g. broken syringe tip; loose or detached leur-lock, or broken finger flange) o If yes, describe in detail how it is broken: Leur-lock is broken off o Provide the exact location of the breakage on the syringe? Tip below Leur-lock o Is the tip of the syringe or Luer-lock adaptor loose or broken off of the syringe tip? YES (if yes describe): Broken Off o Was there difficulty trying to attach the syringe needle to the syringe? NA o If yes, describe NA o If yes, was it supplied by MERCK: NA o If not supplied by MERCK, what type & brand, needle size & gauge was used?' NA Under what situation was this defect noticed: (select one) o While the syringe was still in the tray? YES; If yes, is there product (liquid or dried residue) in the tray? YES o Is there any broken glass or other separated component in the tray? (if yes specify) Yes o After removing the syringe from the tray? NO; While trying to attach the needle to the syringe? NO o While giving the injection? NO; Immediately after g1v1ng the injection? NO; Was the syringe tip cap attached properly prior to use? NA o If no, describe issue: Was the syringe tray intact and undamaged on receipt? YES o If no, describe damage; If the product came with a cellophane cover, was the cellophane covering the syringe tray intact and completely sealed? *See below. YES o If no, describe damage; Was the syringe carton damaged prior to use? (i.e. crushed, ripped, unglued) NO o If yes, describe; Was the product administered or exposed to patient' s bodily fluids (i.e. biohazardous)? NO; If complaint sample is not/cannot be returned, please provide reason: Caller will save for return; 18-NOV-2021, attached email and embedded pictures in a PDF file as well. See attachments. No new PQC. No additional information; 18-NOV-2021, based on the review of the PQC the priority for this record had been changed per Product Quality Complaint, Complaint Category and Risk Priority Table; 18-NOV-2021; Second person reviewed; 18-NOV-2021, at 15:30: Attachment added to Service Cloud; 18-NOV-2021 at 15:30: UPS Labels created Shipped on 18-NOV-2021; 19-NOV-2021: Second person reviewed performed for follow up activity.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-